Which region will provide more business opportunities for growth of methotrexate drugs market in future?

Pfizer Inc., Azurity Pharmaceuticals, Inc., Cumberland Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Sandoz Inc, Hikma Pharmaceuticals PLC, Eisai Co., Ltd. Read More

Methotrexate Drugs Market Size

Q: What would be the CAGR of methotrexate drugs Market over the forecast period?

The methotrexate drugs market size was valued at USD 562.46 Million in 2023 and is expected to exceed USD 815.63 Million by 2036, registering over 2.9% CAGR during the forecast period i.e., between 2024-2036. The surge in the prevalence of rheumatoid arthritis and the increasing prevalence of cancer are the major factors driving the market growth.. Read More

Global Methotrexate Drug Market TOC

Market Definition
1. Definition
2. Market Segmentation
3. Product Overview
Assumptions and Acronyms
Research Methodology
1. Research Process
2. Primary Research
  1. Manufacturers
  2. Suppliers/Distributors
  3. End-Users
3. Secondary Research
4. Market Size Estimation
Analyst Review
Executive Summary – Global Methotrexate Drug Market
Market Dynamics
1. Growth Drivers
2. Restraints
3. Market Trends
4. Opportunities
Regulatory and Standards Landscape
1. FDA
2. WHO
3. Others
Industry Risk Analysis
World Economic Outlook: Challenges for Global Recovery and its Impact on Global Methotrexate Drug Market
Impact of COVID-19 on the Global Methotrexate Drug Market
Epidemiology Analysis of Cancer and Rheumatoid Arthritis
End-user analysis
Industry Supply Chain Analysis
Competitive Landscape
1. Company Market Share Analysis
2. Company Profiles
  1. Pfizer Inc.
  2. Azurity Pharmaceuticals, Inc.
  3. Cumberland Pharmaceuticals Inc.
  4. Teva Pharmaceuticals USA, Inc.
  5. Amneal Pharmaceuticals LLC
  6. Sun Pharmaceutical Industries Ltd.
  7. Aurobindo Pharma Limited,
  8. Sandoz Inc
  9. Hikma Pharmaceuticals PLC
  10. Eisai Co., Ltd.
  11. Other prominent players
Global Methotrexate Drug Market 2023-2036
1. Market Overview
2. By Value (USD Million)
  1. By Type
    1. >10 mg, 2023-2036F (USD Million)
    2. >15 mg/ml, 2023-2036F (USD Million)
    3. 17.5 mg/ml – 25 mg/ml, 2023-2036F (USD Million)
    4. Others, 2023-2036F (USD Million)
  2. By Disease Type
    1. Cancer, 2023-2036F (USD Million)
      1. Breast Cancer, 2023-2036F (USD Million)
      2. Leukemia, 2023-2036F (USD Million)
      3. Lung Cancer, 2023-2036F (USD Million)
      4. Lymphoma, 2023-2036F (USD Million)
      5. Gestational Trophoblastic Disease, 2023-2036F (USD Million)
      6. Osteosarcoma, 2023-2036F (USD Million)
    2. Autoimmune Diseases, 2023-2036F (USD Million)
      1. Psoriasis, 2023-2036F (USD Million)
      2. Rheumatoid Arthritis, 2023-2036F (USD Million)
      3. Crohn's Disease, 2023-2036F (USD Million)
      4. Others, 2023-2036F (USD Million)
    3. Ectopic Pregnancy, 2023-2036F (USD Million)
    4. Others, 2023-2036F (USD Million)
  3. By Drug Type
    1. Branded, 2023-2036F (USD Million)
    2. Generics, 2023-2036F (USD Million)
  4. By Route Of Administration
    1. Injectable, 2023-2036F (USD Million)
    2. Oral, 2023-2036F (USD Million)
  5. By End User
    1. Hospitals, 2023-2036F (USD Million)
    2. Specialty Clinics, 2023-2036F (USD Million)
    3. Home Healthcare, 2023-2036F (USD Million)
    4. Others, 2023-2036F (USD Million)
  6. By Region
    1. North America, 2023-2036F (USD Million)
    2. Europe, 2023-2036F (USD Million)
    3. Asia Pacific, 2023-2036F (USD Million))
    4. Latin America, 2023-2036F (USD Million)
    5. Middle East & Africa, 2023-2036F (USD Million)
North America Methotrexate Drug Market 2023-2036
1. Market Overview
2. By Value (USD Million)
  1. By Type
    1. >10 mg, 2023-2036F (USD Million)
    2. >15 mg/ml, 2023-2036F (USD Million)
    3. 17.5 mg/ml – 25 mg/ml, 2023-2036F (USD Million)
    4. Others, 2023-2036F (USD Million)
  2. By Disease Type
    1. Cancer, 2023-2036F (USD Million)
      1. Breast Cancer, 2023-2036F (USD Million)
      2. Leukemia, 2023-2036F (USD Million)
      3. Lung Cancer, 2023-2036F (USD Million)
      4. Lymphoma, 2023-2036F (USD Million)
      5. Gestational Trophoblastic Disease, 2023-2036F (USD Million)
      6. Osteosarcoma, 2023-2036F (USD Million)
    2. Autoimmune Diseases, 2023-2036F (USD Million)
      1. Psoriasis, 2023-2036F (USD Million)
      2. Rheumatoid Arthritis, 2023-2036F (USD Million)
      3. Crohn's Disease, 2023-2036F (USD Million)
      4. Others, 2023-2036F (USD Million)
    3. Ectopic Pregnancy, 2023-2036F (USD Million)
    4. Others, 2023-2036F (USD Million)
  3. By Drug Type
    1. Branded, 2023-2036F (USD Million)
    2. Generics, 2023-2036F (USD Million)
  4. By Route Of Administration
    1. Injectable, 2023-2036F (USD Million)
    2. Oral, 2023-2036F (USD Million)
  5. By End User
    1. Hospitals, 2023-2036F (USD Million)
    2. Specialty Clinics, 2023-2036F (USD Million)
    3. Home Healthcare, 2023-2036F (USD Million)
    4. Others, 2023-2036F (USD Million)
  6. By Country
    1. United States, 2023-2036F (USD Million)
    2. Canada, 2023-2036F (USD Million)
Europe Methotrexate Drug Market 2023-2036
1. Market Overview
2. By Value (USD Million)
  1. By Type
  2. By Disease Type
  3. By Drug Type
  4. By Route Of Administration
  5. By End User
  6. By Country
    1. United Kingdom, 2023-2036F (USD Million)
    2. Germany, 2023-2036F (USD Million)
    3. France, 2023-2036F (USD Million)
    4. Italy, 2023-2036F (USD Million)
    5. Spain, 2023-2036F (USD Million)
    6. Russia, 2023-2036F (USD Million)
    7. Netherlands, 2023-2036F (USD Million)
    8. Rest of Europe, 2023-2036F (USD Million)
Asia Pacific Methotrexate Drug Market 2023-2036
1. Market Overview
2. By Value (USD Million)
  1. By Type
  2. By Disease Type
  3. By Drug Type
  4. By Route Of Administration
  5. By End User
  6. By Country
    1. China, 2023-2036F (USD Million)
    2. India, 2023-2036F (USD Million)
    3. Japan, 2023-2036F (USD Million)
    4. South Korea, 2023-2036F (USD Million)
    5. Singapore, 2023-2036F (USD Million)
    6. Australia, 2023-2036F (USD Million)
    7. Rest of Asia Pacific, 2023-2036F (USD Million)
Latin America Methotrexate Drug Market 2023-2036
1. Market Overview
2. By Value (USD Million)
  1. By Type
  2. By Disease Type
  3. By Drug Type
  4. By Route Of Administration
  5. By End User
  6. By Country
    1. Brazil, 2023-2036F (USD Million)
    2. Mexico, 2023-2036F (USD Million)
    3. Argentina, 2023-2036F (USD Million)
    4. Rest of Latin America, 2023-2036F (USD Million)
Middle East & Africa Methotrexate Drug Market 2023-2036
1. Market Overview
2. By Value (USD Million)
  1. By Type
  2. By Disease Type
  3. By Drug Type
  4. By Route Of Administration
  5. By End User
  6. By Country
    1. Israel, 2023-2036F (USD Million)
    2. GCC, 2023-2036F (USD Million)
    3. South Africa, 2023-2036F (USD Million)
    4. Rest of Middle East & Africa, 2023-2036F (USD Million)

Methotrexate Drugs Market Size

Methotrexate Drugs Market size was valued at USD 562.46 Million in 2023 and is expected to exceed USD 815.63 Million by 2036, registering over 2.9% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of methotrexate drugs is assessed at USD 578.31 Million. The demand for methotrexate drugs is owing to the increasing use of the drugs for various inflammatory diseases such as rheumatoid arthritis, juvenile rheumatoid arthritis, and lupus. About 60% of people with rheumatoid arthritis are presently taking methotrexate, which is the recommended first-line treatment for rheumatoid arthritis, according to the American College of Rheumatology.

Moreover, the rising prevalence of autoimmune diseases is driving the demand for methotrexate drugs across the globe. As manufacturers are focusing on innovating new drugs in order to reduce the challenges faced by patients.

Methotrexate Drugs Market Size

Methotrexate Drugs Market Size

Browse Key Market Insights with Data Illustration:

Frequently Asked Questions (FAQ)

Subscribe to Our Newsletters

Methotrexate Drugs Market Size

Methotrexate Drugs Market Size

Browse Key Market Insights with Data Illustration:

Frequently Asked Questions (FAQ)

How much is the methotrexate drugs market worth?

Why is the demand for methotrexate drugs growing?

Which region dominated the majority of methotrexate drugs industry share?

Who are the top methotrexate drugs companies?